Figure 10.
Decrease in aconitase enzyme activity (mean ± SEM) in allografts (n = 9) compared with isografts (n = 5) and prevention of loss of activity by treating allograft recipients with CsA or L-NIL (n = 5 each). *, P < 0.05 vs. isografts.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.